Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis

Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis

Background: Tadalafil has been approved for the treatment of benign prostatic hyperplasia (BPH) for nearly 10 years. However, there are insufficient evidence-based studies of the efficacy and safety of tadalafil in treating lower urinary tract symptoms of BPH (LUTS/BPH).Objective: To evaluate the th...

Full description

Bibliographic Details
Main Authors: Jianwei Cui, Dehong Cao, Yunjin Bai, Jiahao Wang, Shan Yin, Wuran Wei, Yunfei Xiao, Jia Wang, Qiang Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Medicine
Subjects:
benign prostatic hyperplasia (BPH)
lower urinary tract symptoms (LUTS)
tadalafil
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.744012/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.744012/full

Similar Items